GH Secretagogue Stack Research Compounds WADA Prohibited

Ipamorelin
& CJC-1295

Ipamorelin: NNC 26-0161 · CJC-1295: DAC:GRF · Drug Affinity Complex

"The most popular GH secretagogue stack in existence. CJC-1295 sustains the baseline. Ipamorelin fires the pulse. Together they mimic youthful GH patterns more completely than either alone — the tortoise and the hare as relay partners."

Ipamorelin
Ghrelin receptor agonist · 5 AA
CJC-1295
GHRH analogue · DAC modified
Half-lives
Ipa: ~2h · CJC: 6–8 days
FDA Status
Not approved · Research compounds
WADA
Prohibited
Origin & Background

Pulse & sustain — the GH stack

Ipamorelin was first described in a landmark 1998 paper by Raun et al. as "the first selective growth hormone secretagogue" — notable because it stimulated GH release without the cortisol, prolactin, or ACTH elevations seen with earlier GH secretagogues like GHRP-2 and GHRP-6. That selectivity made it uniquely clean for body composition applications.

CJC-1295 is a GHRH analogue with a Drug Affinity Complex (DAC) modification — a chemical anchor that binds to albumin in the bloodstream and dramatically extends its half-life from minutes to 6–8 days. A 2006 Phase II trial in healthy adults by Teichman et al. (published in JCEM) showed that a single dose produced sustained, dose-dependent increases in GH and IGF-1 lasting up to 28 days — a landmark result for a GHRH analogue.

Neither compound is FDA-approved as a drug. They are available through compounding pharmacies and are among the most prescribed peptides at anti-ageing and functional medicine clinics globally. The combination emerged from the logic that CJC-1295 sustains the GHRH signal while ipamorelin amplifies individual GH pulses — covering two complementary aspects of GH physiology simultaneously.

The "pulse and sustain" mechanism: CJC-1295 maintains an elevated GHRH baseline over days, priming the pituitary. Ipamorelin then triggers sharp GH pulses through a completely different receptor (GHSR — the ghrelin receptor). Studies suggest the combination produces 3–5x more GH release than either compound alone, because they activate two distinct pathways simultaneously.

Science & Mechanism

Two peptides, two receptors

How They Work Together

1
CJC-1295 — GHRHR pathway: Binds to GHRH receptors on pituitary somatotrophs. The DAC modification binds albumin, creating a depot that continuously releases active peptide over 6–8 days. This "raises the floor" of GH secretion — maintaining steady elevated baseline GH and IGF-1.
2
Ipamorelin — GHSR pathway: Binds to the ghrelin receptor (growth hormone secretagogue receptor) on pituitary cells. Acts independently of the GHRH pathway. Triggers rapid, sharp GH pulses — the "spike" on top of CJC-1295's elevated baseline. Half-life ~2 hours; effect peaks within 30–60 minutes.
3
Selectivity — why ipamorelin is different: Raun's 1998 study established that ipamorelin does not stimulate cortisol, ACTH, prolactin, or aldosterone at therapeutic doses — making it the cleanest GH secretagogue known. GHRP-2 and GHRP-6 stimulate cortisol and hunger; ipamorelin does not.
4
IGF-1 downstream: Combined GH elevation from both pathways drives hepatic IGF-1 production. IGF-1 mediates the anabolic, lipolytic, and regenerative effects. The combination's 3–5x GH amplification translates to correspondingly greater IGF-1 elevation.
5
Feedback preservation: Both compounds work through the pituitary's natural mechanisms. Somatostatin feedback still operates, providing a regulatory ceiling. This is physiologically safer than direct GH injection but the ceiling is higher and more sustained than natural secretion.
Community Voices

What people report

Anecdotal ReportNot medical evidence · Individual experience

"Six weeks in and the sleep quality was unlike anything I've experienced since my twenties. Deep, vivid, and I'm waking up actually recovered. Body composition is shifting — gaining muscle without changing my training. Still early but I understand the hype now."

Male, 44, using compounded CJC-1295/Ipamorelin blend. Sleep quality improvement is the most consistent early report — occurring before visible body composition changes because GH primarily pulses during slow-wave sleep.

Anecdotal ReportNot medical evidence · Individual experience

"I've tried sermorelin and standalone ipamorelin. The combination is noticeably stronger. IGF-1 went from 145 to 230 ng/mL at 4 months. My physician is monitoring and comfortable. The water retention at higher doses is real though — dialling back fixed it."

Female, 51, functional medicine patient with regular IGF-1 monitoring. Water retention is the most frequently reported side effect and is dose-dependent — most users find a lower dose resolves it while maintaining benefits.

Benefits & Evidence

What the data shows

💪
Lean muscle mass and body composition
GH and IGF-1 increase protein synthesis and nitrogen retention. Most users report significant body composition improvements over 3–6 months when combined with resistance training. The IGF-1 elevation from the combination is substantially greater than from either compound alone.
● Moderate — extrapolated from GH/IGF-1 data
🔥
Fat loss — particularly visceral
GH has direct lipolytic effects, mobilising stored fat for energy. CJC-1295 Phase II data (2006) showed significant increases in mean GH and IGF-1 associated with improved metabolic markers. Visceral fat is particularly responsive to GH-axis restoration.
● Moderate — CJC Phase II trial evidence
💤
Sleep quality and recovery
GH secretion is tightly coupled to slow-wave sleep. Raising GH signalling deepens slow-wave sleep in a positive feedback loop. Recovery from training accelerates significantly — typically the first noticeable effect.
● Moderate — consistent across reports
🩹
Tissue repair and injury recovery
IGF-1 drives satellite cell activation and protein synthesis in muscle and connective tissue. Evidence is mixed — a 2020 pilot study showed GH secretagogues preserved muscle strength after ACL reconstruction; a 2024 in vitro study showed no direct tendon cell effect. The systemic IGF-1 elevation likely matters more than any direct GH effect.
● Limited — mixed evidence
⚡
Energy, cognition and anti-ageing
GH insufficiency produces fatigue, cognitive fog and reduced wellbeing. Restoring GH/IGF-1 toward younger levels addresses these symptoms. Most consistent in adults over 40 with measurable GH decline.
● Moderate — consistent with GH restoration
Safety First

Risks & considerations

⚠️
Use with medical supervision. Neither compound is FDA-approved. The elevated IGF-1 produced by this combination is substantially greater than sermorelin alone and requires regular monitoring. Long-term safety data is limited — clinical use is based on extrapolation from GH physiology rather than direct long-term trials of this specific combination.
Mild
Water retention — the most common complaint. IGF-1-mediated sodium retention causes bloating and joint puffiness. Dose-dependent and reversible. Usually resolves by reducing dose.
Mild
Injection site reactions — transient redness or discomfort. Common with SubQ administration. Rotate injection sites.
Mild
Headache and flushing — typically in the first few weeks. Usually self-resolving.
Moderate
Elevated IGF-1 — sustained high IGF-1 carries theoretical cancer-promotion risks (IGF-1 is a general growth signal). Regular monitoring and keeping IGF-1 within age-appropriate reference ranges is essential.
Moderate
Insulin sensitivity changes — GH at elevated levels promotes insulin resistance. Monitor fasting glucose and HbA1c during extended protocols.
Serious
Contraindicated in active malignancy — GH axis stimulation is contraindicated in anyone with active cancer or without appropriate oncological clearance.

⚠ Key Warnings

Monitor IGF-1, fasting glucose and HbA1c every 3 months during use. Do not allow IGF-1 to exceed the upper limit of the age-appropriate reference range.
WADA prohibited at all times for all competitive athletes under anti-doping programmes.
CJC-1295 with DAC produces prolonged GH elevation — this cannot be rapidly reversed if side effects appear. Some practitioners prefer CJC-1295 without DAC (Mod-GRF 1-29) for more controllable shorter-acting effects.
These are research compounds. Quality and dosing accuracy vary significantly between compounding pharmacies — use PCAB-accredited facilities.
Synergy Stack

Nutrients, Supplements & Exercise

This combination already produces significant GH and IGF-1 elevation. The synergy stack focuses on maximising what that elevated hormonal environment can achieve, and managing the risks that come with it.

💊 Nutrients & Supplements
Protein (1.8–2.4g/kg/day)
Essential — prioritise leucine-rich sources
Strong evidence
GH and IGF-1 drive mTOR-dependent muscle protein synthesis — but amino acids are the required substrate. Without adequate protein, the anabolic signal from elevated GH/IGF-1 has no raw material to work with. This is the most important dietary co-factor.
Creatine monohydrate
5g/day
Strong evidence
The most evidence-backed anabolic supplement. Creatine and GH/IGF-1 work through complementary pathways — creatine increases phosphocreatine availability for high-intensity work; GH/IGF-1 drives the muscle growth that follows. Combined effect is greater than either alone.
Avoid carbohydrates at injection time
Fast 2–3 hours before injection
Strong evidence
Insulin suppresses GH release — injecting in a high-insulin state blunts the GH pulse from ipamorelin. Always inject fasted or 2–3 hours post-meal. This is especially critical for the bedtime dose where the largest GH pulse occurs.
Zinc
15–25mg/day with food
Moderate evidence
Required for GH receptor expression and IGF-1 signalling. Deficiency creates a ceiling on how effectively elevated GH can exert its effects at the tissue level.
Magnesium glycinate
300–400mg before bed
Moderate evidence
Deepens slow-wave sleep — directly amplifying the nightly GH pulse that this combination is designed to produce. Most of GH secretion occurs during slow-wave sleep; poor sleep quality wastes a significant portion of the protocol's effect.
🏃 Exercise & Lifestyle
Resistance training — essential
GH and IGF-1 drive muscle growth in response to mechanical load — not at rest. Training the muscles you want to grow directs the elevated anabolic signal where it's needed. Without consistent resistance training, the majority of the body composition benefit is lost.
Evening training + bedtime injection
Training in the late afternoon or evening creates a natural GH pulse; injecting ipamorelin before bed then adds a second amplified pulse during slow-wave sleep. Stacking these two GH pulses is the most effective timing strategy for body composition goals.
Sleep optimisation
The largest GH pulse of the day occurs in the first 90 minutes of slow-wave sleep. Consistent sleep timing (same bedtime and wake time) maximises slow-wave sleep and therefore the effectiveness of the bedtime injection protocol.
⏱ Timing & Protocol Notes
Most common protocol: CJC-1295 (with DAC) 1–2mg SubQ once or twice weekly. Ipamorelin 200–300mcg SubQ nightly before bed, fasted. Some practitioners prefer 3x daily ipamorelin dosing (morning, post-workout, bedtime). CJC without DAC (Mod-GRF 1-29) can be injected alongside ipamorelin 3x daily for a more controllable shorter-acting version. Cycle: 12–16 weeks on, 4–8 weeks off.

Disclaimer: These recommendations are educational. These are research compounds without FDA approval. Regular IGF-1, fasting glucose and HbA1c monitoring is required. Consult a physician experienced with peptide therapy before starting.

Honest Assessment

Editor's summary

The ipamorelin/CJC-1295 combination is the most widely used GH secretagogue stack for a reason — the complementary dual-receptor mechanism is genuinely more effective than either compound alone, and ipamorelin's selectivity (no cortisol, no prolactin, no hunger stimulation) makes it cleaner than older GHRPs.

The honest caution: these are research compounds, not approved drugs. The IGF-1 elevation is substantial and sustained — more so than sermorelin — which means the theoretical long-term risks around cell proliferation deserve respect. Anyone considering this combination should be regularly monitoring IGF-1, working with a physician, and cycling rather than running indefinitely.

For the right candidate — adults with confirmed GH decline, clear body composition goals, access to physician monitoring, and willingness to cycle properly — this is probably the most effective hormonal optimisation tool in this book outside of approved GLP-1 agents.

Verdict
"The most effective GH secretagogue combination available. Dual-receptor mechanism, clean ipamorelin selectivity, and real clinical data on CJC-1295. Requires more rigorous monitoring than sermorelin and carries greater risks — but delivers greater results for those who manage it properly."